High Expression of the Inhibitory Receptor BTLA in T-Follicular Helper Cells and in B-Cell Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
- 1 October 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 132 (4), 589-596
- https://doi.org/10.1309/ajcpphkgyyggl39c
Abstract
B- and T-lymphocyte attenuator (BTLA) is a lymphoid receptor that inhibits lymphocyte activation on interaction with its ligand, herpesvirus entry mediator (HVEM). We developed monoclonal antibodies against BTLA and HVEM to study their expression using immunohistochemical and flow cytometric analyses in human tissues. In reactive lymph nodes, they were both expressed in interfollicular T cells and in B cells from mantle and marginal zones. Within germinal centers, B cells were negative, whereas T follicular helper (TFH) cells were BTLA+ and follicular dendritic cells were HVEM+. BTLA was strongly expressed in chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL, 19 of 19 positive) when compared with other small B-cell lymphomas, including follicular lymphoma (0 of 24 positive), mantle cell lymphoma (0 of 10 positive), and marginal zone lymphoma (0 of 5 positive). Our results suggest that down-regulation of the BTLA-HVEM pathway may be involved in germinal center B-cell activation. The specific high expression of BTLA in B-CLL/SLL represents a new potential diagnostic tool. The BTLA positivity of TFH cells may be a basis for designing future immunotherapies.Keywords
This publication has 35 references indexed in Scilit:
- A crucial role for HVEM and BTLA in preventing intestinal inflammationThe Journal of Experimental Medicine, 2008
- CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediatorNature Immunology, 2008
- In vivo imaging studies shed light on germinal-centre developmentNature Reviews Immunology, 2007
- Imaging of Germinal Center Selection Events During Affinity MaturationScience, 2007
- Programmed Death-1 (PD-1) is a Marker of Germinal Center-associated T Cells and Angioimmunoblastic T-Cell LymphomaThe American Journal of Surgical Pathology, 2006
- A limited number of genes are involved in the differentiation of germinal center B cellsJournal of Cellular Biochemistry, 2006
- NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumorsBlood, 2006
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosusArthritis & Rheumatism, 2004
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003